Pfizer's Sandwich site officially on the block; Acorda gets upgrade on Ampyra sales;

@FiercePharma: Pfizer just might postpone Viagra's patent cliff. News | Follow @FiercePharma

> Pfizer's giant research base at Sandwich, England, has been officially put on the market by CB Richard Ellis following the U.S. drugmaker's decision in February to close the site. Report

> A Citi Investment Research analyst upgraded shares of Acorda Therapeutics, saying the stock is trading at a fair price but could move higher because of strong sales of its Ampyra multiple sclerosis drug. Item

> One year after launching its Bad Ad program--designed to encourage healthcare professionals to report misleading drug promotions--the agency says it's working. Story

> KV Pharmaceutical posted a loss of $174 million in fiscal 2011, compared with a loss of $285.6 million in the prior fiscal year. Article

> Orangetown, NY, may soon approve a settlement of tax challenges by Wyeth Holdings, a subsidiary of Pfizer, over the property assessment of the drug company's Pearl River campus. Piece

> A new meningococcal vaccine just introduced in West Africa has produced very encouraging results, according to the public-private partnership coordinating its distribution. Report

Biotech News

@FierceBiotech: Merck strikes $720M deal with Hanwha for generic Enbrel. Story | Follow @FierceBiotech

@JohnCFierce: The pressure on Forest Labs to do something dramatic has increased considerably today. Wonder what comes next. Follow @JohnCFierce

> E&Y dissects biotech's toughest challenges. Story 

> pSivida forges $169M Pfizer pact for eye drug delivery program. Item 

> For sale: Giant drug research hub. Report 

> Can Biocon get a $1B pharma deal for its oral insulin program? Article

> Array BioPharma axes 70 as it cuts back on discovery work. News 

> Cancer immunotherapies in vogue as specialists seek a "cure." Report 

> Scientists warn on "dead space" as pharma giants shun neuropsych. Story 

Biotech Research News

> Researchers, companies quick to crack E. coli case. News

> The X-Men factor: We inherit 60 mutations from mom and dad. Item

> Three genetic perps fingered for migraine risk. Story

> Complex, spontaneous genetic mutations may be at root of autism. Report

> Scientists often use adult, embryonic stem cells in tandem. News

Manufacturing News

> FDA drives consent decree with H&P/Triad. Story

> Biogen maps way to future factory. Item

> FDA tests nano waters, reorganizes CDER. Article

> DoJ bark may be bigger than bite in Gilead probe. Story 

> Experts: Target distribution for cost savings. News 

> Polish artist uses wooden pallets in his creations. Item 

And Finally... U.S. doctors are too quick to reach for their prescription pads, according to a report urging them to think more about side effects and non-drug alternatives. Report